An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea

Exhaled breath contains thousands of volatile organic compounds (VOCs) in gaseous form, which may be used as markers of airway inflammation and lung disease. Electronic noses enable quick and real-time pattern analysis of VOC spectra. It has been shown that the exhaled breath of patients with obstructive sleep apnoea (OSA) differs from that of non-obese controls. We aimed to assess the influence of obesity in the composition of exhaled VOCs by comparing obese subjects with and without OSA. Moreover, we aimed to identify the discriminant VOCs in the two groups.19 obese patients with established OSA (OO; age 51.2 ± 6.8; body mass index (BMI) 34.3 ± 3.5), 14 obese controls without OSA (ONO; age 46.5 ± 7.6; BMI 33.5 ± 4.1) and 20 non-obese healthy controls (HC; age 41.1 ± 12.6; BMI 24.9 ± 3.8) participated in a cross-sectional study. Exhaled breath was collected by a previously described method and sampled by using an electronic nose (Cyranose 320) and by gas chromatography-mass spectrometry (GC-MS) analysis. Breathprints were analyzed by canonical discriminant analysis on principal component reduction. Cross-validation accuracy (CVA) was calculated. Breathprints from the HC group were separated from those of OO (CVA = 97.4%) and ONO (CVA = 94.1%). Breathprints from OO were moderately separated from those of ONO (CVA = 67.6%).The presence of OSA alters the exhaled VOC pattern in obese subjects. The incomplete separation of breathprints between OO and ONO may be due to the same underlying inflammation caused by obesity.

[1]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[2]  I. Koutsourelakis,et al.  Exhaled breath markers in patients with obstructive sleep apnoea , 2008, Sleep and Breathing.

[3]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[4]  Marcel Zeelenberg,et al.  Data analysis 2 , 2016 .

[5]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[6]  A. Spanevello,et al.  Airway inflammation in patients affected by obstructive sleep apnea syndrome. , 2004, Respiratory medicine.

[7]  J. Horton,et al.  Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. , 1993, Journal of applied physiology.

[8]  A. Spanevello,et al.  Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects , 2007, Journal of internal medicine.

[9]  I. Horváth,et al.  Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose , 2015, Sleep and Breathing.

[10]  Ferran Barbé,et al.  Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea , 2011, European Respiratory Journal.

[11]  Christian Gluud,et al.  Evidence based diagnostics , 2005, BMJ : British Medical Journal.

[12]  Philipp Lirk,et al.  Mass spectrometric profile of exhaled breath—field study by PTR-MS , 2005, Respiratory Physiology & Neurobiology.

[13]  Monica Casale,et al.  Stepwise orthogonalization of predictors in classification and regression techniques: An “old” technique revisited , 2007 .

[14]  E. Vittinghoff,et al.  Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial , 2003, Annals of Internal Medicine.

[15]  M P van der Schee,et al.  External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  T. Greulich,et al.  Detection of obstructive sleep apnoea by an electronic nose , 2012, European Respiratory Journal.

[17]  M. Littner,et al.  Practice parameters for the indications for polysomnography and related procedures: an update for 2005. , 2005, Sleep.

[18]  P. Sterk,et al.  Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  L. Palmer,et al.  Obstructive Sleep Apnoea: From pathogenesis to treatment: Current controversies and future directions , 2010, Respirology.

[20]  Bruce R. Kowalski,et al.  An orthogonal feature selection method , 1976, Pattern Recognit..

[21]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Chongsuvivatwong,et al.  Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. , 2009, Sleep medicine.

[23]  P. J. Callahan,et al.  Volatile organic compounds as breath biomarkers for active and passive smoking. , 2002, Environmental health perspectives.

[24]  Bogusław Buszewski,et al.  Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.

[25]  Ildikó Horváth,et al.  Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome. , 2013, International journal of pediatric otorhinolaryngology.

[26]  Onofrio Resta,et al.  8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. , 2003, Chest.

[27]  A. Spanevello,et al.  Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. , 2008, Translational research : the journal of laboratory and clinical medicine.

[28]  L. Trizio,et al.  Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure , 2010, Analytical and bioanalytical chemistry.

[29]  M. Tschöp,et al.  High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. , 2000, Cytokine.

[30]  P. Scheff,et al.  Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. , 1997, Chest.

[31]  N. Lewis,et al.  Exploitation of spatiotemporal information and geometric optimization of signal/noise performance using arrays of carbon black-polymer composite vapor detectors , 2002 .

[32]  Begoña Garcia-Zapirain,et al.  EEG artifact removal—state-of-the-art and guidelines , 2015, Journal of neural engineering.